Main Hong Kong in pioneering life sciences innovation within the Larger Bay Space and setting an instance for the area
HONG KONG–(BUSINESS WIRE)–Hong Kong Science and Expertise Parks (HKSTP) continues to strengthen its strategic partnership with AstraZeneca, one of many world’s main pharmaceutical corporations. The purpose of this collaboration is to place Hong Kong and the Larger Bay Space as pioneers in life science innovation and function a job mannequin for the area. This marks a milestone that HKSTP has entered right into a multi-dimensional collaboration, together with know-how and information sharing, with a life sciences firm.
Since 2021, AstraZeneca and HKSTP have been collaborating and this partnership is not going to solely proceed however may even be enhanced. The expanded collaboration entails AstraZeneca and HKSTP supporting and offering providers to startups below the HKSTP co-incubation programme. As well as, the partnership consists of attracting extra abroad and mainland Chinese language corporations to the HKSTP neighborhood, with the purpose of connecting them with hospitals, key opinion leaders within the Larger Bay Space, and universities in Hong Kong.
The 2022 political tackle underscored town’s dedication to selling innovation and know-how. AstraZeneca and HKSTP share the identical aspiration to work with the Hong Kong SAR authorities to enhance Hong Kong’s healthcare ecosystem.
AstraZeneca may even advise on establishing worldwide workplaces in Hong Kong and help the connection of abroad buyers with HKSTP co-incubation programmes. As well as, roadshow classes can be held at HKSTP for abroad and China healthcare R&D conferences to construct non-traditional partnerships throughout geographic borders, facilitating collaborative motion and opening up new alternatives to boost innovation enabled by the affected person.
The MOU was signed by Shan Wu, Basic Supervisor of AstraZeneca Hong Kong and Macau, and Albert Wong, Chief Govt Officer of HKSTP, at a ceremony attended by Sir Pascal Soriot, Chief Govt Officer of AstraZeneca, Leon Wang, Govt Vice President, Worldwide and China President of AstraZeneca, and Dr Sunny Chai, President of HKSTP.
Dr Sunny Chai, President of HKSTP, expressed his delight to witness the collaboration between HKSTP and AstraZeneca in constructing a healthcare innovation ecosystem in Hong Kong. Biotechnology is vital not just for Hong Kong’s financial improvement, but in addition for mankind. Consistent with the Hong Kong Innovation and Expertise Improvement Blueprint, HKSTP is totally dedicated to paving the best way for its success by welcoming world expertise, corporations and funding to learn from Hong Kong’s confirmed observe file in R&D, superior manufacturing and in advertising and marketing. This newest settlement is one other vital milestone in our partnership with AstraZeneca and additional builds on the constructive momentum inside HKSTP’s biotech ecosystem.
Ms Lillian Cheong, Undersecretary for Innovation, Expertise and Trade, stated: Selling I&T improvement is without doubt one of the SAR Authorities’s prime priorities. The Nationwide Fourteenth 5-Yr Plan additionally offers agency help for Hong Kong’s improvement as a global I&T hub. The SAR Authorities has proposed to concentrate on industries with a bonus, together with life and well being applied sciences, and formulate engaging particular facilitation measures to draw outstanding corporations to set foot in Hong Kong or increase their current companies right here. I’m glad to see the cooperation between AZHK and HKSTP which isn’t solely a testomony to Hong Kong’s nice R&D capabilities in life and well being know-how, but in addition demonstrates the cooperation between the upstream and downstream industries. I sit up for becoming a member of all of you in totally seizing the golden improvement alternatives forward.
Leon Wang, Govt Vice President, Worldwide and China President of AstraZeneca, expressed his enthusiasm for the partnership between HKSTP and AstraZeneca. As a world pharmaceutical chief with robust ties to enterprise leaders, scientists, entrepreneurs and buyers world wide, AstraZeneca is nicely geared up to assist nurture extra well being expertise and drive important progress in medical analysis, drug improvement and in Hong Kong medical trial trials.
Dr Grace Lau, Head of the Institute for Translational Analysis, HKSTP, highlighted the significance of attracting bigger multinationals to change into co-incubators and set up R&D laboratories throughout the HKSTP ecosystem. Companies present invaluable mentorship, sharing their assets and experience with startups. HKSTP has already established partnerships with multinationals working innovation facilities abroad, successfully extending their incubation program to different elements of the world. Moreover, they hope to draw extra high quality startups to Hong Kong with the assistance of those multinational companions.
About Hong Kong Science and Expertise Parks Company
Hong Kong Science and Expertise Parks Company (HKSTP) has been dedicated to constructing Hong Kong as a global innovation and know-how hub for over 20 years to foster the success of native and world pioneers at the moment and tomorrow. HKSTP has created a thriving I&T ecosystem internet hosting two unicorns and Hong Kong’s main R&D hub with greater than 12,000 analysis professionals and greater than 1,200 know-how corporations centered on well being know-how, synthetic intelligence and robotics, fintech and good metropolis applied sciences.
Based in 2001, we entice and nurture expertise, speed up and commercialize innovation and know-how for entrepreneurs on their progress journey in Hong Kong, the Larger Bay Space, Asia and past. Our rising innovation ecosystem is constructed round our key places of Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three trendy INNOPARKs in Tai Po, Tseung Kwan O and Yuen Lengthy. The three INNOPARKS are realizing a imaginative and prescient of latest industrialization for Hong Kong. The purpose is for industries akin to superior manufacturing, electronics and biotechnology to be reinvented for a brand new industrial technology.
Via our infrastructure, providers, experience and partnership community, HKSTP will assist set up innovation and know-how as a progress pillar for Hong Kong whereas strengthening Hong Kong’s standing as a global I&T hub as a stepping stone to launch for world progress on the coronary heart of the GBA innovation powerhouse.
Extra details about HKSTP is offered at www.hkstp.org.
About AstraZeneca
AstraZeneca is a science-led world biopharmaceutical firm centered on the invention, improvement and commercialization of prescription medicines in oncology, uncommon illnesses and biopharmaceuticals, together with cardiovascular, renal and metabolic and respiratory and immunology. Headquartered in Cambridge, UK, AstraZeneca operates in over 100 nations and its revolutionary medicines are utilized by thousands and thousands of sufferers world wide. For extra info, go to www.astrazeneca.com.hk.
Contacts
Common:
PRPPL Consultancy Restricted
Lee Sze Ala
Phone: +852 9811 3380
E mail: w.lee@prppl.com
Edelmann Public Relations
Sonia Leung
Phone: +852 2837 4775
E mail: Sonia.Leung@edelman.com/ Edelmanhkstppr@edelman.com
Hong Kong Science & Expertise Parks Company
Julia Cheung
Phone: +852 2629 6891
E mail: julia.cheung@hkstp.org